单中心型Castleman病经18F-FDG PET/CT与99mTc-HYNIC-TOC生长抑素受体显像揭示
Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
PubMed 文献 · Clin Nucl Med · 2018-01-01
51岁女性,有高血压和腹痛病史,发现腹膜后肿块。增强CT示肿块明显强化,PET/CT示FDG摄取中度增高,99mTc-HYNIC-TOC生长抑素受体显像阳性,而I-MIBG扫描阴性。手术切除后组织病理证实为Castleman病透明血管型。
要点
- 腹膜后肿块在增强CT上明显强化,在18F-FDG PET/CT上呈中度FDG摄取增高。
- 99mTc-HYNIC-TOC生长抑素受体显像阳性,而I-MIBG扫描阴性。
- 手术切除标本的组织病理结果证实为Castleman病透明血管型。
核心结论
- 51岁女性腹膜后肿块经18F-FDG PET/CT与99mTc-HYNIC-TOC生长抑素受体显像发现,手术切除后组织病理证实为Castleman病透明血管型。
研究设计与样本
- 病例报告:1例51岁女性,有高血压和腹痛病史,发现腹膜后肿块。
主要发现
- 增强CT示腹膜后肿块明显强化,PET/CT示该肿块FDG摄取中度增高。
- 该肿块在99mTc-HYNIC-TOC生长抑素受体显像中为阳性,在I-MIBG扫描中为阴性。
- 手术切除肿块后组织病理确诊为Castleman病透明血管型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 51-year-old woman with a history of hypertension and abdominal pain was found with a retroperitoneal mass. The mass had intense enhancement in contrast-enhanced CT, and it showed a moderate degree of increased FDG uptake in PET/CT. The mass was also positive in somatostatin receptor scintigraphy with Tc-HYNIC-TOC, but it was negative in I-MIBG scan. The histopathological result after surgical resection of the mass confirmed the diagnosis of Castleman's disease, the hyaline vascular variant.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Luo Y, Wang L, Pan Q, et al. Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC. Clin Nucl Med. 2018. PMID: 29742598. doi:10.1097/RLU.0000000000002124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。